These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 1608408)

  • 1. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes.
    Avorn J; Soumerai SB; Everitt DE; Ross-Degnan D; Beers MH; Sherman D; Salem-Schatz SR; Fields D
    N Engl J Med; 1992 Jul; 327(3):168-73. PubMed ID: 1608408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
    Ray WA; Taylor JA; Meador KG; Lichtenstein MJ; Griffin MR; Fought R; Adams ML; Blazer DG
    Arch Intern Med; 1993 Mar; 153(6):713-21. PubMed ID: 8447709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study.
    Avorn J; Dreyer P; Connelly K; Soumerai SB
    N Engl J Med; 1989 Jan; 320(4):227-32. PubMed ID: 2911307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychoactive medication use in intermediate-care facility residents.
    Beers M; Avorn J; Soumerai SB; Everitt DE; Sherman DS; Salem S
    JAMA; 1988 Nov; 260(20):3016-20. PubMed ID: 2903260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an interdisciplinary educational program on antipsychotic prescribing among nursing home residents with dementia.
    Monette J; Champoux N; Monette M; Fournier L; Wolfson C; du Fort GG; Sourial N; Le Cruguel JP; Gore B
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):574-9. PubMed ID: 17968860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland.
    Gobert M; D'hoore W
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):712-21. PubMed ID: 16035123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in northern ireland (fleetwood northern ireland study).
    Patterson SM; Hughes CM; Crealey G; Cardwell C; Lapane KL
    J Am Geriatr Soc; 2010 Jan; 58(1):44-53. PubMed ID: 20002510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drug prescriptions for nursing home residents.
    Burns BJ; Kamerow DB
    J Fam Pract; 1988 Feb; 26(2):155-60. PubMed ID: 3339319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of extrapyramidal signs in nursing home patients given antipsychotic medication.
    Avorn J; Monane M; Everitt DE; Beers MH; Fields D
    Arch Intern Med; 1994 May; 154(10):1113-7. PubMed ID: 7910451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consumption of psychopharmaceuticals in residential facilities for the elderly. Evaluation of the extent, indications and effects].
    Nilsson L; Petersson C
    Lakartidningen; 2001 Mar; 98(12):1371-3. PubMed ID: 11320786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restraint use among nursing home residents: cross-sectional study and prospective cohort study.
    Meyer G; Köpke S; Haastert B; Mühlhauser I
    J Clin Nurs; 2009 Apr; 18(7):981-90. PubMed ID: 19284433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consumption of psychopharmaceuticals by residents at nursing homes. Significance of the environment at the nursing home].
    Hasle H; Olsen RB
    Ugeskr Laeger; 1989 May; 151(21):1313-6. PubMed ID: 2734920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents.
    Monane M; Glynn RJ; Avorn J
    Clin Pharmacol Ther; 1996 Jan; 59(1):83-92. PubMed ID: 8549038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a restraint reduction intervention and OBRA '87 regulations on psychoactive drug use in nursing homes.
    Siegler EL; Capezuti E; Maislin G; Baumgarten M; Evans L; Strumpf N
    J Am Geriatr Soc; 1997 Jul; 45(7):791-6. PubMed ID: 9215327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopharmaceutical prescriptions to older people. A comparison between patients in aged- and nursing homes, outpatient treatment with nursing care and outpatients without nursing care].
    Hach I; Rentsch A; Krappweis J; Kirch W
    Z Gerontol Geriatr; 2004 Jun; 37(3):214-20. PubMed ID: 15224242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate use of psychotropic drugs in nursing homes.
    Gurvich T; Cunningham JA
    Am Fam Physician; 2000 Mar; 61(5):1437-46. PubMed ID: 10735348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home study.
    Lipley N
    Nurs Stand; 2000 Sep 27-Oct 3; 15(2):18-9. PubMed ID: 11971404
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes.
    Soumerai SB; Ross-Degnan D; Avorn J; McLaughlin Tj; Choodnovskiy I
    N Engl J Med; 1991 Oct; 325(15):1072-7. PubMed ID: 1891009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.